Tilray Brands, Inc. (NASDAQ:TLRY) Looks Inexpensive After Falling 39% But Perhaps Not Attractive Enough

Simply Wall St.

Nov 25

The Tilray Brands, Inc. (NASDAQ:TLRY) share price has fared very poorly over the last month, falling by a substantial 39%. Instead of being rewarded, shareholders who have already held through the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2586924444"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2586924444\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2586924444?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","is_english":true,"pubTime":"2025-11-25 02:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2586924444","market":"hk","top_or_hot":-1,"title":"Tilray Brands, Inc. (NASDAQ:TLRY) Looks Inexpensive After Falling 39% But Perhaps Not Attractive Enough","media":"Simply Wall St.","content":"<div>\n<p>The Tilray Brands, Inc. (NASDAQ:TLRY) share price has fared very poorly over the last month, falling by a substantial 39%.    Instead of being rewarded, shareholders who have already held through the ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tlry/tilray-brands/news/tilray-brands-inc-nasdaqtlry-looks-inexpensive-after-falling\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Brands, Inc. (NASDAQ:TLRY) Looks Inexpensive After Falling 39% But Perhaps Not Attractive Enough</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Brands, Inc. (NASDAQ:TLRY) Looks Inexpensive After Falling 39% But Perhaps Not Attractive Enough\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-25 02:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tlry/tilray-brands/news/tilray-brands-inc-nasdaqtlry-looks-inexpensive-after-falling><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Tilray Brands, Inc. (NASDAQ:TLRY) share price has fared very poorly over the last month, falling by a substantial 39%.    Instead of being rewarded, shareholders who have already held through the ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tlry/tilray-brands/news/tilray-brands-inc-nasdaqtlry-looks-inexpensive-after-falling\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4557","symbol_name":"大麻股","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tlry/tilray-brands/news/tilray-brands-inc-nasdaqtlry-looks-inexpensive-after-falling","article_id":"2586924444","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tlry/tilray-brands/news/tilray-brands-inc-nasdaqtlry-looks-inexpensive-after-falling","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2586924444","pubTimestamp":1764007835,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"The Tilray Brands, Inc. ( NASDAQ:TLRY ) share price has fared very poorly over the last month, falling by a substantial...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4557":"大麻股","USAW.SI":"AMZN 3xLongSG261006","QLD":"2倍做多纳斯达克100指数ETF-ProShares","TQQQ":"纳指三倍做多ETF","TLRY":"Tilray Inc.","BK4007":"制药","BK4596":"哈里斯概念","QID":"两倍做空纳斯达克指数ETF-ProShares","PSQ":"做空纳斯达克100指数ETF-ProShares","TSYW.SI":"TESLA 3xLongSG261006","NVIW.SI":"NVDA 3xLongSG261006","SQQQ":"纳指三倍做空ETF",".IXIC":"NASDAQ Composite","USJW.SI":"ALPHAB 3xLongSG261006","BK4547":"WSB热门概念"},"translate_title":"Tilray Brands, Inc.（纳斯达克股票代码：TLRY）在下跌39%后看起来很便宜，但可能不够有吸引力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MNQmain":0.6,"QID":0.6,"TQQQ":0.6,"USAW.SI":0.6,"NQmain":0.6,"PSQ":0.6,"TLRY":1.5,"USJW.SI":0.6,"QLD":0.6,"TSYW.SI":0.6,"NVIW.SI":0.6,"SQQQ":0.6,".IXIC":1.5},"content_text":"The Tilray Brands, Inc. (NASDAQ:TLRY) share price has fared very poorly over the last month, falling by a substantial 39%.    Instead of being rewarded, shareholders who have already held through the last twelve months are now sitting on a 36% share price drop.    Following the heavy fall in price, Tilray Brands' price-to-sales (or \"P/S\") ratio of 1.2x might make it look like a strong buy right now compared to the wider Pharmaceuticals industry in the United States, where around half of the companies have P/S ratios above 4x and even P/S above 18x are quite common.   Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly reduced P/S.    AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.  Check out our latest analysis for Tilray Brands NasdaqGS:TLRY Price to Sales Ratio vs Industry November 24th 2025Advertisement What Does Tilray Brands' Recent Performance Look Like?  Tilray Brands could be doing better as it's been growing revenue less than most other companies lately.   Perhaps the market is expecting the current trend of poor revenue growth to continue, which has kept the P/S suppressed.  If you still like the company, you'd be hoping revenue doesn't get any worse and that you could pick up some stock while it's out of favour.      Keen to find out how analysts think Tilray Brands' future stacks up against the industry? In that case, our free report is a great place to start.  Is There Any Revenue Growth Forecasted For Tilray Brands?   The only time you'd be truly comfortable seeing a P/S as depressed as Tilray Brands' is when the company's growth is on track to lag the industry decidedly.   Retrospectively, the last year delivered virtually the same number to the company's top line as the year before.   Still, the latest three year period has seen an excellent 35% overall rise in revenue, in spite of its uninspiring short-term performance.  Accordingly, shareholders will be pleased, but also have some questions to ponder about the last 12 months.     Shifting to the future, estimates from the nine analysts covering the company suggest revenue should grow by 4.5% per year over the next three years.  Meanwhile, the rest of the industry is forecast to expand by 29% per year, which is noticeably more attractive.  With this in consideration, its clear as to why Tilray Brands' P/S is falling short industry peers.  Apparently many shareholders weren't comfortable holding on while the company is potentially eyeing a less prosperous future.    What We Can Learn From Tilray Brands' P/S?  Having almost fallen off a cliff, Tilray Brands' share price has pulled its P/S way down as well.      While the price-to-sales ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of revenue expectations.  As we suspected, our examination of Tilray Brands' analyst forecasts revealed that its inferior revenue outlook is contributing to its low P/S.  Shareholders' pessimism on the revenue prospects for the company seems to be the main contributor to the depressed P/S.  It's hard to see the share price rising strongly in the near future under these circumstances.      You need to take note of risks, for example - Tilray Brands has 3 warning signs   (and 1 which is significant) we think you should know about.   If strong companies turning a profit tickle your fancy, then you'll want to check out this free list of interesting companies that trade on a low P/E (but have proven they can grow earnings). Valuation is complex, but we're here to simplify it.Discover if Tilray Brands might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}